These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1714651)
41. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide. Eng CP; Gullo-Brown J; Chang JY; Sehgal SN Transplant Proc; 1991 Feb; 23(1 Pt 1):868-9. PubMed ID: 1990708 [No Abstract] [Full Text] [Related]
42. High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis. Pham SM; Shears LL; Kawaharada N; Li S; Venkataramanan R; Sehgal S Transplant Proc; 1998 Jun; 30(4):953-4. PubMed ID: 9636385 [No Abstract] [Full Text] [Related]
43. Hamster-to-rat xenotransplantation of whole pancreas by FK 506 combined with splenectomy. Ohtsuka S; Hayashi S; Sato E; Negita M; Kobayashi T; Orihara A; Yokoyama I; Takagi H Transplant Proc; 1994 Apr; 26(2):781. PubMed ID: 7513473 [No Abstract] [Full Text] [Related]
44. Endocrine function of the rejecting rat pancreas. Perks G; Jablonski P; Howden BO; Marshall VC; Scott DF Transplant Proc; 1989 Feb; 21(1 Pt 1):500-1. PubMed ID: 2468220 [No Abstract] [Full Text] [Related]
45. Effects of a combined antigen-cyclosporine regimen in four transplantation models. Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626 [No Abstract] [Full Text] [Related]
46. Beneficial immunosuppressive effect of FTY720 combined with intrathymic injection of splenic cells on rat pancreaticoduodenal allograft. Suzuki K; Kazui T; Kawabe A; Li XK; Amemiya H; Suzuki S Transplant Proc; 1998 Jun; 30(4):1067-8. PubMed ID: 9636432 [No Abstract] [Full Text] [Related]
47. Rapamycin in experimental liver transplantation in the rat. Yoshimura N; Ohsaka Y; Hamashima T; Yasui H; Yura H; Kobayashi Y; Shiho O; Oka T Transplant Proc; 1996 Jun; 28(3):1796-7. PubMed ID: 8658887 [No Abstract] [Full Text] [Related]
48. Differential immunosuppressive strategies after combined pancreaticoduodenal and isolated kidney transplantation. Mellert J; Hopt UT; Büsing M; Hölzer H Transplant Proc; 1990 Aug; 22(4):1584-5. PubMed ID: 2389412 [No Abstract] [Full Text] [Related]
49. Prolongation of allograft survival with Ling Zhi-8, a new immunosuppressive drug. van der Hem LG; van der Vliet JA; Bocken CF; Kino K; Hoitsma AJ; Tax WJ Transplant Proc; 1994 Apr; 26(2):746. PubMed ID: 8171639 [No Abstract] [Full Text] [Related]
50. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection. Schmid C; Heemann U; Azuma H; Tilney NL Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053 [No Abstract] [Full Text] [Related]
51. Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor. Troppmann C; Papalois BE; Gruessner AC; Moon C; Matas AJ; Nakhleh RE; Gruessner RW Transplant Proc; 1996 Apr; 28(2):842-4. PubMed ID: 8623429 [No Abstract] [Full Text] [Related]
53. Prolongation of pancreaticoduodenal allograft survival in rats by treatment with FK 506. Yamashita T; Maeda Y; Ishikawa T; Ohira M; Nakagawa H; Nagai Y; Park I; Yamamoto Y; Yoshikawa K; Cai R Transplant Proc; 1991 Dec; 23(6):3219-20. PubMed ID: 1721414 [No Abstract] [Full Text] [Related]
54. Successful canine pancreaticoduodenal allotransplantation with cyclosporine and gabexate mesilate. Morimoto T; Sakamoto J; Chikashige T; Nishimura M; Yasui K; Yasue M; Miyaishi S; Uchida K; Kano T; Takagi H Transplant Proc; 1987 Feb; 19(1 Pt 2):1318-20. PubMed ID: 3152627 [No Abstract] [Full Text] [Related]
55. Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury. Gregory CR; Huie P; Shorthouse R; Wang J; Rowan R; Billingham ME; Morris RE Transplant Proc; 1993 Feb; 25(1 Pt 1):120-1. PubMed ID: 8438246 [No Abstract] [Full Text] [Related]
56. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion. Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269 [No Abstract] [Full Text] [Related]
57. Fetal pancreas transplantation in non-obese diabetic (NOD) mice. A comparison of iso-, allo- and xenografts. Mandel TE; Koulmanda M; Bacelj A Horm Metab Res Suppl; 1990; 25():166-73. PubMed ID: 2088961 [TBL] [Abstract][Full Text] [Related]
58. Long-term studies of pancreas allotransplantation in experimental diabetes mellitus. Lee S; Scott MH; Yancey D; Allen J; Chang ES; Chisari F; Moossa AR Microsurgery; 1988; 9(3):217-21. PubMed ID: 3054415 [TBL] [Abstract][Full Text] [Related]